electroCore, Inc., a commercial-stage medical device company, is dedicated to the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is headquartered in Rockaway, New Jersey.
| Revenue (TTM) | $32.03M |
| Gross Profit (TTM) | $27.79M |
| EBITDA | $-12.65M |
| Operating Margin | -31.80% |
| Return on Equity | -478.70% |
| Return on Assets | -42.00% |
| Revenue/Share (TTM) | $3.78 |
| Book Value | $-0.21 |
| Price-to-Book | 41.88 |
| Price-to-Sales (TTM) | 1.59 |
| EV/Revenue | 1.465 |
| EV/EBITDA | 0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 31.20% |
| Shares Outstanding | $8.08M |
| Float | $5.12M |
| % Insiders | 37.30% |
| % Institutions | 10.48% |
Volatility is currently expanding